drugset / Trial / NCT00654745
18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To determine if olmesartan plus amlodipine combination therapy alone and with hydrochlorothiazide will be safe and effective to reduce high blood pressure in hypertensive, type 2 diabetic subjects.
Timeline
- Start
- 2008-05
- Primary completion
- 2009-04
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | — |
| Subject | Amlodipine | Other / unclassified | 10 mg | — |
| Subject | Hydrochlorothiazide | Unknown | 12.5 mg | — |
| Subject | Hydrochlorothiazide | Unknown | 25 mg | — |
| Subject | Olmesartan medoxomil | Unknown | 20 mg | — |
| Subject | Olmesartan medoxomil | Unknown | 40 mg | — |